健康资讯 Karuna Therapeutics(KRTX)：
Karuna Therapeutics(KRTX) 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-23-004225 Size: 7 KB 网页链接
Karuna Therapeutics(KRTX)：
Karuna Therapeutics(KRTX) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001306550-23-005080 Act: 34 Size: 13 KB 网页链接
Karuna Therapeutics(KRTX)：
Karuna Therapeutics(KRTX) SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-010753 Act: 34 Size: 142 KB 网页链接
Karuna Therapeutics(KRTX)：
Karuna Therapeutics(KRTX) 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0000950170-23-001635 Act: 34 Size: 195 KB 网页链接
产业链观察：
#药闻简讯# Karuna Therapeutics(KRTX) 宣布与Goldfinch Bio公司的研究性TRPC4/5产品候选物达成全球独家许可协议
KRTX将支付1500万美元的预付款+高达5.2亿美元的里程碑（4.1亿美元的注册和销售）+平坦的低个位数版税
Karuna Therapeutics(KRTX)：
Karuna Therapeutics(KRTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-004228 Size: 7 KB 网页链接
